These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 28756384

  • 1. Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case-control study.
    Li C, Zhou ML, Liang DD, Wang JJ, Yang J, Zeng CH, Liu ZH, Zhang HT.
    BMJ Open; 2017 Jul 28; 7(7):e015668. PubMed ID: 28756384
    [Abstract] [Full Text] [Related]

  • 2. Serum antineutrophil cytoplasmic antibody positivity at the time of renal biopsy is associated with disease activity of lupus nephritis.
    Zhang J, Lian R, Chen Y, Wan J.
    Ren Fail; 2024 Dec 28; 46(2):2357743. PubMed ID: 38847502
    [Abstract] [Full Text] [Related]

  • 3. Differences in clinico-pathological characteristics and outcomes between proteinase 3-ANCA positivity and myeloperoxidase-ANCA positivity in lupus nephritis.
    Li C, Wang JJ, Zhou ML, Liang DD, Yang J, Zhu HX, Hu WX, Zhang HT.
    Lupus; 2019 Aug 28; 28(9):1111-1119. PubMed ID: 31291845
    [Abstract] [Full Text] [Related]

  • 4. ANCA positivity at the time of renal biopsy is associated with chronicity index of lupus nephritis.
    Pyo JY, Jung SM, Song JJ, Park YB, Lee SW.
    Rheumatol Int; 2019 May 28; 39(5):879-884. PubMed ID: 30806732
    [Abstract] [Full Text] [Related]

  • 5. Clinicopathological and outcome analysis of adult lupus nephritis patients in China.
    Tang Y, Zhang X, Ji L, Mi X, Liu F, Yang L, Qin W.
    Int Urol Nephrol; 2015 Mar 28; 47(3):513-20. PubMed ID: 25563231
    [Abstract] [Full Text] [Related]

  • 6. Clinical features and outcomes of patients with antineutrophil cytoplasmic antibody-positive systemic lupus erythematosus.
    Wang Y, Yu X, Xie X, Li H, Yang W, Liang Y, Lu W.
    Ren Fail; 2023 Dec 28; 45(1):2235431. PubMed ID: 37470370
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcomes in antineutrophil cytoplasmic autoantibody-positive eosinophilic granulomatosis with polyangiitis patients with renal involvement: a retrospective study of 14 Chinese patients.
    Chen Y, Ding Y, Liu Z, Zhang H, Liu Z, Hu W.
    BMC Nephrol; 2016 Jul 26; 17(1):101. PubMed ID: 27461086
    [Abstract] [Full Text] [Related]

  • 8. Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil.
    Joo YB, Kang YM, Kim HA, Suh CH, Kim TJ, Park YW, Lee J, Lee JH, Yoo DH, Bae SC, Lee HS, Bang SY.
    Int J Rheum Dis; 2018 May 26; 21(5):1031-1039. PubMed ID: 29611341
    [Abstract] [Full Text] [Related]

  • 9. Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.
    Smith E, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley D, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Ramanan A, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Beresford MW, Hedrich CM.
    Lupus; 2019 Apr 26; 28(5):613-620. PubMed ID: 30871425
    [Abstract] [Full Text] [Related]

  • 10. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
    Pradhan VD, Badakere SS, Bichile LS, Almeida AF.
    J Assoc Physicians India; 2004 Jul 26; 52():533-7. PubMed ID: 15645975
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathologic characteristics and outcomes of lupus nephritis with positive antineutrophil cytoplasmic antibody.
    Wang S, Shang J, Xiao J, Zhao Z.
    Ren Fail; 2020 Nov 26; 42(1):244-254. PubMed ID: 32228220
    [Abstract] [Full Text] [Related]

  • 12. Antineutrophil Cytoplasmic Antibody in Lupus Nephritis: Correlation with Clinicopathological Characteristics and Disease Activity.
    Said D, Rashad NM, Abdelrahmanc NS, Dawaa GA.
    Curr Rheumatol Rev; 2021 Nov 26; 17(2):213-221. PubMed ID: 33292154
    [Abstract] [Full Text] [Related]

  • 13. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.
    Ginzler EM, Wofsy D, Isenberg D, Gordon C, Lisk L, Dooley MA, ALMS Group.
    Arthritis Rheum; 2010 Jan 26; 62(1):211-21. PubMed ID: 20039429
    [Abstract] [Full Text] [Related]

  • 14. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.
    Momtaz M, Fayed A, Wadie M, Gamal SM, Ghoniem SA, Sobhy N, Kamal Elden NM, Hamza WM.
    Lupus; 2017 Dec 26; 26(14):1564-1570. PubMed ID: 28625079
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
    Hu W, Liu C, Xie H, Chen H, Liu Z, Li L.
    Nephrol Dial Transplant; 2008 Apr 26; 23(4):1307-12. PubMed ID: 18065810
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission in Nonlife-Threatening Relapses of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Randomized, Controlled Trial.
    Tuin J, Stassen PM, Bogdan DI, Broekroelofs J, van Paassen P, Cohen Tervaert JW, Sanders JS, Stegeman CA.
    Clin J Am Soc Nephrol; 2019 Jul 05; 14(7):1021-1028. PubMed ID: 31253599
    [Abstract] [Full Text] [Related]

  • 17. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K, Yu Y, Tang Z, Liu Z, Li L.
    Chin Med J (Engl); 1997 Jul 05; 110(7):502-7. PubMed ID: 9594205
    [Abstract] [Full Text] [Related]

  • 18. Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
    Wang J, Hu W, Xie H, Zhang H, Chen H, Zeng C, Liu Z, Li L.
    Lupus; 2007 Jul 05; 16(9):707-12. PubMed ID: 17728363
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review.
    Lacetera R, Calatroni M, Roggero L, Radice A, Pozzi MR, Reggiani F, Sciascia S, Trezzi B, Roccatello D, Minetti E, Moroni G, Sinico RA.
    J Nephrol; 2023 May 05; 36(4):1059-1070. PubMed ID: 36940001
    [Abstract] [Full Text] [Related]

  • 20. Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis.
    Cooper JC, Rouster-Stevens K, Wright TB, Hsu JJ, Klein-Gitelman MS, Ardoin SP, Schanberg LE, Brunner HI, Eberhard BA, Wagner-Weiner L, Mehta J, Haines K, McCurdy DK, Phillips TA, Huang Z, von Scheven E, CARRA registry investigators.
    Pediatr Rheumatol Online J; 2018 Oct 22; 16(1):65. PubMed ID: 30348175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.